Trial	Phase	Sponsor	Dist.
Left vs Left Randomized Clinical Trial	N/A	Baylor College of Medicine	<1 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events	Phase 3	Amgen	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	<1 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function	Phase 3	AstraZeneca	<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin	Phase 3	AstraZeneca	<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity	Phase 3	SWOG Cancer Research Network	<1 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment	—	Children's Oncology Group	<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products	—	Medtronic	<1 mi
Product Surveillance Registry	—	Medtronic	<1 mi
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders	Phase 3	Ascendis Pharma A/S	<1 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II	N/A	Shockwave Medical, Inc.	<1 mi
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System	N/A	Biosense Webster, Inc.	<1 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma	—	Children's Oncology Group	<1 mi
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)	Phase 3	Colorado Prevention Center	<1 mi
Assessment of CCM in HF With Higher Ejection Fraction	N/A	Impulse Dynamics	<1 mi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Phase 3	Novo Nordisk A/S	<1 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	Phase 3	Amgen	<1 mi
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)	Phase 3	Boehringer Ingelheim	<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant	Phase 3	Eidos Therapeutics, a BridgeBio company	<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure	N/A	Abbott Medical Devices	<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	<1 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative	—	Children's Hospital of Philadelphia	<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Phase 3	Johns Hopkins University	<1 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy	Phase 4	Dennis M. McNamara, MD, MS	<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS	Phase 3	DalCor Pharmaceuticals	<1 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients	Phase 3	Colorado Prevention Center	<1 mi
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2	Phase 3	Tenax Therapeutics, Inc.	<1 mi
PARTNER 3 Trial - Aortic Valve-in-Valve	N/A	Edwards Lifesciences	<1 mi
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions	N/A	Boston Scientific Corporation	<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.	N/A	Medtronic Cardiovascular	<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Phase 3	Yale University	<1 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women	N/A	Weill Medical College of Cornell University	<1 mi
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension	Phase 2	Retension Pharmaceuticals. Inc.	<1 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study	Phase 2/3	Kardigan, Inc.	<1 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A	Endotronix, Inc.	<1 mi
Minima Stent System Post- Approval Study (PAS)	—	Renata Medical	<1 mi
The Fourth Left Atrial Appendage Occlusion Study	N/A	Hamilton Health Sciences Corporation	<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)	N/A	University of Michigan	<1 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR	N/A	Edwards Lifesciences	<1 mi
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction	N/A	Edwards Lifesciences	<1 mi
Optimal Ventilation for Cardiac Arrest	N/A	Children's Hospital of Philadelphia	<1 mi
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation	N/A	Biosense Webster, Inc.	<1 mi
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists	Phase 3	Colorado Prevention Center	<1 mi
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation	N/A	Arga Medtech SA	<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE	—	Medtronic Cardiovascular	<1 mi
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis	Phase 2/3	Kiniksa Pharmaceuticals International, plc	<1 mi
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)	N/A	Medtronic Cardiac Ablation Solutions	<1 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)	N/A	Biosense Webster, Inc.	<1 mi
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)	N/A	Medtronic Cardiac Ablation Solutions	<1 mi
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial	N/A	University of Texas at Austin	<1 mi
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry	—	University of Kansas Medical Center	<1 mi
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor	—	Peerbridge Health, Inc	<1 mi
Transition to KPL-387 Monotherapy Dosing & Administration Study	Phase 2	Kiniksa Pharmaceuticals International, plc	<1 mi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention	Phase 4	Duke University	<1 mi
The ENCIRCLE Trial	N/A	Edwards Lifesciences	<1 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System	N/A	Boston Scientific Corporation	<1 mi
A Post-Market Assessment of the Safety and Performance of the TriClip™ System	—	Abbott Medical Devices	<1 mi
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation	N/A	Boston Scientific Corporation	<1 mi
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF	N/A	Massachusetts General Hospital	<1 mi
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study	N/A	AtaCor Medical, Inc.	<1 mi
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study	N/A	W.L.Gore & Associates	<1 mi
AMEND TS Early Feasibility Study	N/A	Valcare Medical Ltd.	<1 mi
Cord Clamping Among Neonates With Congenital Heart Disease	N/A	Carl Backes, MD	<1 mi
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
Ketones, SGLT2, HFrEF	Early 1	The University of Texas Health Science Center at San Antonio	<1 mi
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM	—	Cordio Medical	<1 mi
EFS of the DUO System for Tricuspid Regurgitation	N/A	CroiValve Limited	<1 mi
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).	N/A	Mayra Guerrero	<1 mi
AngelMed Guardian® System PMA Post Approval Study	—	Angel Medical Systems	<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction	Phase 3	Cytokinetics	<1 mi
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)	Phase 3	Anthos Therapeutics, Inc.	<1 mi
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment	—	Ipsen	<1 mi
CCM OPEN HF Registry	—	Impulse Dynamics	<1 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart	Phase 3	Boehringer Ingelheim	<1 mi
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections	Phase 3	X4 Pharmaceuticals	<1 mi
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure	N/A	Procyrion	<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease	—	Children's Hospital Medical Center, Cincinnati	<1 mi
Abatacept in Immune Checkpoint Inhibitor Myocarditis	Phase 3	Massachusetts General Hospital	<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2	Phase 3	Mezzion Pharma Co. Ltd	<1 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF	Phase 2	Cytokinetics	<1 mi
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment	Phase 2	BioMarin Pharmaceutical	<1 mi
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction	Phase 3	Bayer	<1 mi
Danon Disease Natural History Study	—	Rocket Pharmaceuticals Inc.	<1 mi
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial	Phase 4	VA Office of Research and Development	<1 mi
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy	Phase 3	Alnylam Pharmaceuticals	<1 mi
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery	—	Brigham and Women's Hospital	<1 mi
Prevail Global Study	N/A	Medtronic Vascular	<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)	—	Bristol-Myers Squibb	<1 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)	Phase 2/3	Merck Sharp & Dohme LLC	<1 mi
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy	—	Tenaya Therapeutics	<1 mi
Cardiogenic Shock Working Group Registry	—	Tufts Medical Center	<1 mi
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants	N/A	Nationwide Children's Hospital	<1 mi
FORWARD CAD IDE Study	N/A	Shockwave Medical, Inc.	<1 mi
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy	Phase 2	Novo Nordisk A/S	<1 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	N/A	BrioHealth Solutions, Inc.	<1 mi
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)	Phase 3	Intellia Therapeutics	<1 mi
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events	Phase 2	Genentech, Inc.	<1 mi
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)	Phase 3	Novartis Pharmaceuticals	<1 mi
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve	N/A	Edwards Lifesciences	<1 mi
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction	Phase 3	Bayer	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
Medtronic Cardiac Surgery PMCF Registry	—	Medtronic Cardiac Surgery	<1 mi
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy	Phase 2	Imbria Pharmaceuticals, Inc.	<1 mi
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™	N/A	JenaValve Technology, Inc.	<1 mi
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement	N/A	University of British Columbia	<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG	Phase 3	Icahn School of Medicine at Mount Sinai	<1 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves	N/A	Edwards Lifesciences	<1 mi
J-Valve Transfemoral Pivotal Study	N/A	JC Medical, Inc., an affiliate of Edwards Lifesciences LLC	<1 mi
The CONFORM Pivotal Trial	N/A	Conformal Medical, Inc	<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	N/A	Edwards Lifesciences	<1 mi
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children	—	University of Pennsylvania	<1 mi
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation	N/A	M.D. Anderson Cancer Center	<1 mi
Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers	Phase 2	M.D. Anderson Cancer Center	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block	—	The Hospital for Sick Children	<1 mi
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)	Phase 3	NYU Langone Health	<1 mi
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures	—	Boston Children's Hospital	<1 mi
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)	—	VDI Technologies	<1 mi
Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease	N/A	Georgia State University	<1 mi
Marfan Syndrome Moderate Exercise Trial II	N/A	Baylor College of Medicine	<1 mi
DeBakey Cardiovascular Magnetic Resonance Study	—	Dipan Shah	<1 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)	N/A	P+F Products + Features USA Inc.	<1 mi
Tracking Results of Ablations to Combat AF Registry Generation 2	—	AtriCure, Inc.	<1 mi
Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery	Phase 1	Pacira Pharmaceuticals, Inc	<1 mi
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device	Phase 4	Columbia University	<1 mi
TTVR Early Feasibility Study	N/A	Medtronic Cardiovascular	<1 mi
Venous Ethanol for Ventricular Tachycardia	Phase 2	The Methodist Hospital Research Institute	<1 mi
ViewFlex X ICE First-in-Human Study	—	Abbott Medical Devices	<1 mi
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis	Phase 2	Zomagen Biosciences Ltd.	<1 mi
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)	Phase 2	The University of Texas Health Science Center, Houston	<1 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis	Phase 2	Novartis Pharmaceuticals	<1 mi
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress	Phase 4	Population Health Research Institute	<1 mi
ATrial Tachycardia PAcing Therapy in Congenital Heart	—	Ian Law	<1 mi
BiVACOR® Total Artificial Heart Early Feasibility Study	N/A	BiVACOR Inc.	<1 mi
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)	Phase 3	Cardiol Therapeutics Inc.	<1 mi
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)	Phase 2	Milestone Pharmaceuticals Inc.	<1 mi
Pivotal Study for the Cardiac Performance System (CPS)	—	Sensydia Corporation	<1 mi
Randomized Trial of SGLT2i in Heart Transplant Recipients	Phase 4	VA Office of Research and Development	<1 mi
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM	Phase 1/2	Tenaya Therapeutics	<1 mi
A Phase 2 Study of CRD-4730 in CPVT	Phase 2	Cardurion Pharmaceuticals, Inc.	<1 mi
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy	Phase 2	Roberto Bolli	<1 mi
Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study	—	Centre hospitalier de l'Université de Montréal (CHUM)	<1 mi
Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients	N/A	Baylor College of Medicine	<1 mi
UTHealth Turner Syndrome Research Registry	—	The University of Texas Health Science Center, Houston	<1 mi
Abbott Cephea Mitral Valve Disease Registry	—	Abbott Medical Devices	<1 mi
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry	—	Universitätsklinikum Hamburg-Eppendorf	<1 mi
MYTHS - MYocarditis THerapy With Steroids	Phase 3	Niguarda Hospital	<1 mi
ATLAS (AltaValve) Pivotal Trial	N/A	4C Medical Technologies, Inc.	<1 mi
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs	—	Inova Health Care Services	<1 mi
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure	Phase 1	YAP Therapeutics, Inc.	<1 mi
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry	—	University of Colorado, Denver	<1 mi
Cephea Early Feasibility Study	N/A	Abbott Medical Devices	<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients	Phase 4	University of Rochester	<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR	N/A	Cardiac Dimensions, Inc.	<1 mi
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study	N/A	Brigham and Women's Hospital	<1 mi
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System	N/A	HighLife SAS	<1 mi
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study	N/A	Starlight Cardiovascular Inc	<1 mi
18F-mFBG Cardiac Uptake With Lewy Body Dementia	Phase 2	Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)	<1 mi
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)	Phase 1/2	Nuevocor Pte. Ltd.	<1 mi
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment	—	BillionToOne Inc.	<1 mi
18F-mFBG Imaging for Myocardial Sympathetic Innervation	Phase 2	Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)	<1 mi
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)	Phase 1/2	Affinia Therapeutics	<1 mi
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis	Phase 3	Duke University	<1 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure	Phase 3	Boehringer Ingelheim	<1 mi
SELUTION 4 De Novo Small Vessel IDE Trial	N/A	M.A. Med Alliance S.A.	<1 mi
ELEVATE-HFpEF Clinical Study	N/A	Medtronic Cardiac Rhythm and Heart Failure	<1 mi
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)	N/A	Medtronic Cardiac Ablation Solutions	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
Polypill for Prevention of Cardiomyopathy	Phase 1/2	University of Texas Southwestern Medical Center	<1 mi
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes	N/A	University of Texas Southwestern Medical Center	<1 mi
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study	N/A	University of Texas Southwestern Medical Center	<1 mi
Tailored Exercise Training Study Among Adults With HFpEF	Phase 2/3	University of Texas Southwestern Medical Center	<1 mi
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)	N/A	Baylor Research Institute	<1 mi
Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy	—	University of Texas Southwestern Medical Center	<1 mi
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery	Phase 4	University of California, San Francisco	<1 mi
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System	Phase 2	Stanford University	<1 mi
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction	Phase 1/2	Sardocor Corp.	<1 mi
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass	Phase 3	Octapharma	<1 mi
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels	—	Inova Health Care Services	<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women	Phase 3	Weill Medical College of Cornell University	<1 mi
IEEM-Heat and Heart Failure	N/A	University of Texas Southwestern Medical Center	<1 mi
A Polypill for Acute Coronary Syndrome	Phase 2	University of Texas Southwestern Medical Center	<1 mi
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction	Phase 1	Sardocor Corp.	<1 mi
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation	—	University of Alberta	<1 mi
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients	Phase 2	Baylor Research Institute	<1 mi
STOP AF First Post-Approval Study	—	Medtronic Cardiac Ablation Solutions	<1 mi
The Hepatitis C Transplant Collaborative	—	Baylor Research Institute	<1 mi
PULSED AF Post-Approval Study	—	Medtronic Cardiac Ablation Solutions	<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities	Phase 3	Weill Medical College of Cornell University	<1 mi
MASA Valve Early Feasibility Study	N/A	PECA Labs	<1 mi
BoxX-NoAF Clinical Trial	N/A	AtriCure, Inc.	<1 mi
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients	N/A	University of Texas Southwestern Medical Center	<1 mi
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial	Phase 2/3	VA Office of Research and Development	<1 mi
Cardiopulmonary Stress Testing (CPET) AlloSure Study	—	Baylor Research Institute	<1 mi
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation	Phase 2	University of Texas Southwestern Medical Center	<1 mi
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients	N/A	University of Texas Southwestern Medical Center	<1 mi
The ROle of Compression StocKings in Heart Failure Patients	N/A	University of Maryland, Baltimore	<1 mi
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions	N/A	Teleflex	<1 mi
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk	Phase 3	Population Health Research Institute	<1 mi
South Asians and Coronary Plaque Registry	—	University of Texas Southwestern Medical Center	<1 mi
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions	N/A	Concept Medical Inc.	<1 mi
Get With the Guidelines Atrial Fibrillation Registry	—	American Heart Association	<1 mi
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)	N/A	XVIVO Perfusion	<1 mi
Home-based Cardiac Rehabilitation in Heart Failure	Phase 3	University of Texas Southwestern Medical Center	<1 mi
Get With The Guidelines-Heart Failure Registry	—	American Heart Association	<1 mi
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers	—	University of Texas Southwestern Medical Center	<1 mi
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias	—	Heart Rhythm Clinical and Research Solutions, LLC	<1 mi
Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF	N/A	University of Texas Southwestern Medical Center	<1 mi
Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability	—	University of Texas Southwestern Medical Center	<1 mi
Cardiac Clearance vs G60 Hip Frailty Index	—	Methodist Health System	<1 mi
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable	Phase 3	Regeneron Pharmaceuticals	<1 mi
Improving Veteran Referral to Cardiac Rehabilitation	N/A	VA Office of Research and Development	<1 mi
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System	N/A	Methodist Health System	<1 mi
Venous Compression in Fontan	N/A	University of Texas Southwestern Medical Center	<1 mi
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease	Phase 1	Verve Therapeutics, Inc.	13 mi
EFS of the CardioMech MVRS	N/A	CardioMech AS	18 mi
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing	N/A	Baylor Research Institute	18 mi
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR	—	Baylor Research Institute	18 mi
Clinical Study of the inQB8 TTVR System (The MonarQ Study)	N/A	inQB8 Medical Technologies, LLC	18 mi
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure	N/A	Boston Scientific Corporation	18 mi
Prospective Long-Term Outcomes of a Standardized Ross Procedure	—	Baylor Research Institute	18 mi
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels	N/A	Concept Medical Inc.	18 mi
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)	N/A	Supira Medical	18 mi
CALM Study: Cardiomems Assisted Lvad Management	N/A	Baylor Research Institute	18 mi
Lumason® Infusion vs. Bolus Administrations	Phase 3	Bracco Diagnostics, Inc	18 mi
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial	Phase 3	Amgen	18 mi
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation	N/A	Biosense Webster, Inc.	19 mi
Virtue® SAB in the Treatment of Coronary ISR Trial	N/A	Orchestra BioMed, Inc	21 mi
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)	Phase 2	Pfizer	28 mi
Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders	—	Healing Hope International	28 mi
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation	Phase 2	Regeneron Pharmaceuticals	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.